Saisei Ventures

Cell & Gene Therapy · Venture Capital

Overview

Saisei Ventures is a leading venture capital firm focused on growing and harnessing the Japanese biotech ecosystem; a region rich in opportunities and potential.

Investor profile

Venture capital
Investments
6
4 of them startups
Hiring now
3
15 open roles
Rounds in 12 months
1
$33M raised
Focusshare of its companies
Health Care 80%Biotechnology 60%Data & Analytics 20%Consumer Goods 20%
Where its companies are
Japan 33%
Stage of its companies
Series B 33%Series C and later 33%Series A 33%
Its companies, the freshest money firstAll 6 investments
CraifVenture round $33M · 2 mo ago · 12 roles Optieum BiotechnologiesSeries A $9M · 21 mo ago · 1 role CureAppSeries G $51.5M · 4 yr ago · 2 roles United Immunity Tunetx
15 open roles at 3 of its companies
Co-investorscompanies they hold together
Keio Innovation Initiative 2 shared
Similar investorstheir companies share markets and countries
Claris Ventures Kyoto University Innovation Capital Westlake BioPartners Two River NVCC MPM BioImpact LAV Illumina Ventures
Sources: its portfolio page, read Nov 3

News

News YahooFinance 1 year ago
Saisei Ventures Appoints James Feliciano as Venture Partner
CAMBRIDGE, Mass., September 15, 2025--Saisei Ventures, a leading investment firm focused on advancing Japanese biotechnology and therapeutic innovations, today announced that Mr. James Feliciano has been appointed venture partner.
Read more
Report
News YahooFinance 1 year ago
Saisei Ventures Appoints James Feliciano as Venture Partner
CAMBRIDGE, Mass., September 15, 2025--Saisei Ventures, a leading investment firm focused on advancing Japanese biotechnology and therapeutic innovations, today announced that Mr. James Feliciano has been appointed venture partner.
Read more
Report
News markets.financialcontent.com 1 year ago
Saisei Ventures Launches Executive Fellows Program Aiming to Enhance Japan's Biotech Leadership Pipeline
Saisei Ventures Launches Executive Fellows Program Aiming to Enhance Japan's Biotech Leadership Pipeline
Read more
Report
Press release businesswire.com 1 year ago
Saisei Ventures Launches Executive Fellows Program Aiming to Enhance Japan's Biotech Leadership Pipeline Read more
Report
News markets.financialcontent.com 3 years ago
Saisei Ventures is Selected as a Certified VC Fund by AMED to Catalyze the Japanese Drug Development Ecosystem
Saisei Ventures is Selected as a Certified VC Fund by AMED to Catalyze the Japanese Drug Development Ecosystem
Read more
Report
Press release businesswire.com 3 years ago
Saisei Ventures is Selected as a Certified VC Fund by AMED to Catalyze the Japanese Drug Development Ecosystem Read more
Report